| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.
|
Microbiol Rev
|
1994
|
4.94
|
|
2
|
Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.
|
Infect Immun
|
1986
|
4.34
|
|
3
|
Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro.
|
Proc Natl Acad Sci U S A
|
1993
|
4.28
|
|
4
|
Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells.
|
Infect Immun
|
1978
|
4.26
|
|
5
|
Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice.
|
Infect Immun
|
1997
|
3.12
|
|
6
|
Requirements for ingestion of Chlamydia psittaci by mouse fibroblasts (L cells).
|
Infect Immun
|
1976
|
3.11
|
|
7
|
Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.
|
Infect Immun
|
1983
|
2.77
|
|
8
|
Immediate toxicity of high multiplicities of Chlamydia psittaci for mouse fibroblasts (L cells).
|
Infect Immun
|
1976
|
2.76
|
|
9
|
Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence.
|
Infect Immun
|
1994
|
2.58
|
|
10
|
A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis.
|
Infect Immun
|
1990
|
2.55
|
|
11
|
Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease.
|
Trends Microbiol
|
1994
|
2.54
|
|
12
|
Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages.
|
J Immunol
|
1982
|
2.40
|
|
13
|
Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice.
|
Infect Immun
|
1988
|
2.30
|
|
14
|
Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells).
|
Infect Immun
|
1983
|
2.17
|
|
15
|
Kinetics of phagocytosis of Chlamydia psittaci by mouse fibroblasts (L cells): separation of the attachment and ingestion stages.
|
Infect Immun
|
1978
|
1.94
|
|
16
|
Lymphokine enhances oxygen-independent activity against intracellular pathogens.
|
J Exp Med
|
1983
|
1.93
|
|
17
|
Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae.
|
J Infect Dis
|
1999
|
1.79
|
|
18
|
Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages.
|
J Interferon Res
|
1989
|
1.74
|
|
19
|
Induction of tryptophan degradation in vitro and in vivo: a gamma-interferon-stimulated activity.
|
J Interferon Res
|
1986
|
1.70
|
|
20
|
Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.
|
J Immunol
|
1987
|
1.65
|
|
21
|
Reactivation of persistent Chlamydia trachomatis infection in cell culture.
|
Infect Immun
|
1995
|
1.54
|
|
22
|
Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection.
|
Infect Immun
|
1989
|
1.54
|
|
23
|
IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth.
|
J Immunol
|
1993
|
1.53
|
|
24
|
Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation.
|
Infect Immun
|
1983
|
1.53
|
|
25
|
Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae.
|
Microbes Infect
|
1999
|
1.52
|
|
26
|
Cytochalasin B does not inhibit ingestion of Chlamydia psittaci by mouse fibroblasts (L cells) and mouse peritoneal macrophages.
|
Infect Immun
|
1979
|
1.48
|
|
27
|
T helper type-1 (Th1)/Th2 profiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring.
|
Clin Exp Immunol
|
1996
|
1.48
|
|
28
|
Induction of macrophage foam cell formation by Chlamydia pneumoniae.
|
J Infect Dis
|
1998
|
1.46
|
|
29
|
Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes.
|
J Leukoc Biol
|
1989
|
1.41
|
|
30
|
Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection.
|
Infect Immun
|
1994
|
1.41
|
|
31
|
Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects.
|
Experientia
|
1989
|
1.33
|
|
32
|
Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome.
|
Infect Immun
|
2001
|
1.28
|
|
33
|
Arrays of hemispheric surface projections on Chlamydia psittaci and Chlamydia trachomatis observed by scanning electron microscopy.
|
J Bacteriol
|
1979
|
1.26
|
|
34
|
Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
|
Infect Immun
|
1999
|
1.25
|
|
35
|
A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide.
|
Infect Immun
|
1998
|
1.25
|
|
36
|
Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages.
|
Infect Immun
|
1989
|
1.20
|
|
37
|
Reactivation of chlamydial genital tract infection in mice.
|
Infect Immun
|
1997
|
1.17
|
|
38
|
Role for inducible nitric oxide synthase in protection from chronic Chlamydia trachomatis urogenital disease in mice and its regulation by oxygen free radicals.
|
Infect Immun
|
2001
|
1.15
|
|
39
|
Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture.
|
Infect Immun
|
1998
|
1.14
|
|
40
|
Effect of interferon on a primary conjunctival epithelial cell model of trachoma.
|
Invest Ophthalmol Vis Sci
|
1991
|
1.11
|
|
41
|
Cytokine-mediated indoleamine 2,3-dioxygenase induction in response to Chlamydia infection in human macrophage cultures.
|
Infect Immun
|
1994
|
1.10
|
|
42
|
In vitro expression of factor-mediated cytotoxic activity generated during the immune response to Chlamydia in the mouse.
|
J Immunol
|
1985
|
1.07
|
|
43
|
Differential susceptibility of chlamydiae to exogenous fibroblast interferon.
|
Infect Immun
|
1983
|
1.07
|
|
44
|
Chlamydial heat shock proteins and disease pathology: new paradigms for old problems?
|
Infect Dis Obstet Gynecol
|
1999
|
1.04
|
|
45
|
Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease.
|
Infect Immun
|
2000
|
1.04
|
|
46
|
Interactions between macrophages and chlamydiae.
|
Immunol Ser
|
1994
|
0.99
|
|
47
|
Intracellular tryptophan pool sizes may account for differences in gamma interferon-mediated inhibition and persistence of chlamydial growth in polarized and nonpolarized cells.
|
Infect Immun
|
1999
|
0.99
|
|
48
|
Use of monoclonal antibodies to facilitate identification, cloning, and purification of Chlamydia trachomatis hsp10.
|
J Clin Microbiol
|
1997
|
0.97
|
|
49
|
Upregulation of interferon-induced indoleamine 2,3-dioxygenase in human macrophage cultures by lipopolysaccharide, muramyl tripeptide, and interleukin-1.
|
Cell Immunol
|
1995
|
0.95
|
|
50
|
Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage-lipoprotein interactions.
|
J Infect Dis
|
2000
|
0.92
|
|
51
|
Immunity to Chlamydia: comparison of human infections and murine models.
|
Res Immunol
|
1997
|
0.92
|
|
52
|
Interferon gamma induced production of indoleamine 2,3 dioxygenase in cultured human synovial cells.
|
J Rheumatol
|
1994
|
0.90
|
|
53
|
Effects of interferons beta or gamma on neopterin biosynthesis and tryptophan degradation by human alveolar macrophages in vitro: synergy with lipopolysaccharide.
|
Am J Respir Cell Mol Biol
|
1992
|
0.90
|
|
54
|
Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells.
|
Microbes Infect
|
2001
|
0.89
|
|
55
|
Role of tryptophan in gamma interferon-mediated chlamydial persistence.
|
Ann N Y Acad Sci
|
1994
|
0.84
|
|
56
|
Differential effects of gamma interferon on Chlamydia trachomatis growth in polarized and nonpolarized human epithelial cells in culture.
|
Infect Immun
|
1998
|
0.83
|
|
57
|
Chlamydial treatment failures: a persistent problem?
|
J Eur Acad Dermatol Venereol
|
2001
|
0.80
|
|
58
|
In vivo-activated mononuclear phagocytes and protective immunity to chlamydiae in mice.
|
Infect Immun
|
1988
|
0.80
|
|
59
|
Interferons: from virus inhibitor to modulator of amino acid and lipid metabolism.
|
J Interferon Res
|
1987
|
0.79
|
|
60
|
Inducible nitric oxide synthase regulates production of isoprostanes in vivo during chlamydial genital infection in mice.
|
Infect Immun
|
2003
|
0.79
|
|
61
|
Differential modulation of lymphocyte proliferative responses and lymphokine secretion in mice during development of immunity to Chlamydia psittaci.
|
Infect Immun
|
1989
|
0.79
|
|
62
|
Tryptophan metabolism in chronic inflammatory lung disease.
|
J Lab Clin Med
|
1995
|
0.78
|
|
63
|
Lymphokine stimulated macrophages inhibit intracellular Chlamydia psittaci replication by mechanisms distinct from intracellular inhibition of Toxoplasma gondii replication.
|
Adv Exp Med Biol
|
1983
|
0.77
|
|
64
|
The effect of intracellular Chlamydia psittaci on lysosomal enzyme activities in mouse peritoneal macrophages.
|
Acta Pathol Microbiol Immunol Scand C
|
1987
|
0.76
|
|
65
|
Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
|
J Biol Response Mod
|
1990
|
0.75
|
|
66
|
The challenge of defining disease.
|
Science
|
2001
|
0.75
|
|
67
|
Enhancement of indoleamine 2,3-dioxygenase activity in cancer patients receiving interferon-beta Ser.
|
J Interferon Res
|
1989
|
0.75
|